Thailand has ordered an additional 30 million doses of the Pfizer (NYSE:PFE)/ BioNTech's (Nasdaq:BNTX) COVID-19 vaccine, Reuters news agency reported on Tuesday.
Government spokesman Thanakorn Wangboonkongchana said that delivery under this order is expected to begin in the first quarter of next year.
This latest order is on top of 30 million Pfizer-BioNTech shots due to arrive this year and 60 million doses of the AstraZeneca (LON:AZN) COVID-19 due for 2022.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses